Finextra and Cloudera Report Reveals Hybrid AI is the New Standard in Financial Services, with 91% Citing It as Highly Valuable Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a…
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines
BURBANK, Calif., July 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021
BOSTON, July 08, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused…
Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR or the Company),…
Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021
WATERTOWN, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Amolyt Pharma Announces Appointment of Two Directors
Elisabeth Svanberg, M.D., Ph.D. brings extensive experience in the development of therapeutics for under-served endocrine,…
BeyondSpring to Participate in the William Blair Biotech Focus Conference
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (“BeyondSpring”) (NASDAQ: BYSI), a global…
Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform
Major Release to Help Life Science Companies Maximize Go-to-Market Impact PRINCETON, N.J., July 08, 2021…
aTyr Pharma Announces Last Patient Visit in Phase 1b/2a Clinical Trial of ATYR1923 in Patients with Pulmonary Sarcoidosis
Results from proof-of-concept study are expected in September 2021. SAN DIEGO, July 08, 2021 (GLOBE…
Vaccitech to Present at the William Blair Biotech Focus Conference 2021
OXFORD, United Kingdom, July 08, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage…
Ensysce Biosciences Receives Notice of Award for Year Three of Multi-Year NIDA Grant for the Clinical Development of its Next Generation Opioid Products with Overdose Protection
Company’s Proprietary TAAP Prodrug Delivery and Overdose Technology Aims to Stem The Opioid Abuse Epidemic…
Tiziana Life Sciences plc – ADS Ex-Dividend Date Scheduled for July 09, 2021
THIS ANNOUNCEMENT IS FOR US ADS HOLDERS ONLY NEW YORK, July 08, 2021 (GLOBE NEWSWIRE)…
Generation Bio to Present at William Blair Biotech Focus Conference
CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative…
Windtree to Present at Access to Giving Virtual Investor Conference
WARRINGTON, Pa., July 08, 2021 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology…
ProMIS Neurosciences Obtains Receipt for Final Base Shelf Prospectus
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY,…
Nephros Announces Preliminary Results for Second Quarter of 2021
Anticipates Net Revenue of $2.2 Million, Greater Than 40% Year-Over-Year Increase;Submits HDF Product to FDA…
FDA Approves Updated ADUHELM™ Prescribing Information to Emphasize Population Studied in Clinical Trials
ADUHELM should be initiated in patients with mild cognitive impairment due to Alzheimer’s disease or…
Better Choice Announces Increased Insider Participation
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) — Better Choice Company (NYSE American: BTTR) (“Better…
Trevena Announces First Patient Enrolled in OLINVYK® Phase 3 Trial in China in Partnership with Jiangsu Nhwa Pharmaceutical
Nhwa is conducting and funding this study to support NDA regulatory filing in China Trevena…
Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout
The company will analyze data based on patients enrolled to date in COVID-19 Phase II…